Loading
Latest filing published 26 Oct 2016 for Raptor Pharmaceutical Corp, €69k.
Richard L. Franklin discloses dealings in Raptor Pharmaceutical Corp to SEC (Form 4). Over a trading history stretching from 23 June 2016 to 25 October 2016, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 26 October 2016, reports a transaction of €69k in Raptor Pharmaceutical Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 2 declarations